N
Nupur N. Uppal
Researcher at Hofstra University
Publications - 30
Citations - 3955
Nupur N. Uppal is an academic researcher from Hofstra University. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 8, co-authored 23 publications receiving 604 citations. Previous affiliations of Nupur N. Uppal include Long Island Jewish Medical Center & Jewish Hospital.
Papers
More filters
Journal ArticleDOI
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review.
Rimda Wanchoo,Sabine Karam,Nupur N. Uppal,Valerie S. Barta,Gilbert Deray,Craig Devoe,Vincent Launay-Vacher,Kenar D. Jhaveri +7 more
TL;DR: Although initially thought to be rare, the incidence rates of renal toxicities might be higher as identified by recent studies, Steroids appear to be effective in treating the immune-related adverse effects noted with these agents.
Journal ArticleDOI
COVID-19-Associated Kidney Injury: A Case Series of Kidney Biopsy Findings.
Purva Sharma,Nupur N. Uppal,Rimda Wanchoo,Hitesh H. Shah,Yihe Yang,Rushang Parikh,Yuriy Khanin,Varun Madireddy,Christopher P. Larsen,Kenar D. Jhaveri,Vanesa Bijol +10 more
TL;DR: The most common finding in kidney biopsy samples from ten hospitalized patients with AKI and COVID-19 was acute tubular necrosis, and there was no evidence of SARS-CoV-2 in the biopsied kidney tissue.
Journal ArticleDOI
Outcomes of patients with end-stage kidney disease hospitalized with COVID-19.
Jia H. Ng,Jamie S. Hirsch,Jamie S. Hirsch,Rimda Wanchoo,Mala Sachdeva,Vipulbhai Sakhiya,Susana Hong,Kenar D. Jhaveri,Steven Fishbane,Mersema Abate,Hugo Paz Andrade,Richard Barnett,Alessandro G. Bellucci,Madhu Bhaskaran,Antonio G. Corona,Bessy Suyin Flores Chang,Mark Finger,Michael Gitman,Candice Halinski,Shamir Hasan,Azzour D. Hazzan,Yuriy Khanin,Aireen Kuan,Varun Madireddy,Deepa Malieckal,Abdulrahman Muzib,Gayatri Nair,Jia Hwei Ng,Rushang Parikh,Daniel W. Ross,Richard Schwarz,Hitesh H. Shah,Purva Sharma,Pravin C. Singhal,Nupur N. Uppal,Vinay Nair +35 more
TL;DR: Among patients hospitalized with COVID-19, those with end-stage kidney disease had a higher rate of in-hospital death compared to those without ESKD, and Black race was associated with a lower risk of death.
Journal ArticleDOI
Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury.
Jia H. Ng,Jamie S. Hirsch,Jamie S. Hirsch,Azzour D. Hazzan,Rimda Wanchoo,Hitesh H. Shah,Deepa A. Malieckal,Daniel W. Ross,Purva Sharma,Vipulbhai Sakhiya,Steven Fishbane,Kenar D. Jhaveri,Mersema Abate,Hugo Paz Andrade,Richard Barnett,Alessandro G. Bellucci,Madhu Bhaskaran,Antonio G. Corona,Bessy Suyin Flores Chang,Mark Finger,Michael Gitman,Candice Halinski,Shamir Hasan,Azzour D. Hazzan,Susana Hong,Yuriy Khanin,Aireen Kuan,Varun Madireddy,Deepa Malieckal,Abdulrahman Muzib,Gayatri Nair,Vinay Nair,Jia Hwei Ng,Rushang Parikh,Mala Sachdeva,Richard Schwarz,Pravin C. Singhal,Nupur N. Uppal +37 more
TL;DR: The goal of this study was to investigate the survival and kidney outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19) and acute kidney injury (AKI) and to observe greater risks for in-hospital death for patients with AKI 1-3 and AKI 3D.
Journal ArticleDOI
De Novo ANCA-associated Vasculitis with Glomerulonephritis in COVID-19.
Nupur N. Uppal,Nina Kello,Hitesh H. Shah,Yuriy Khanin,Ivan Ramirez De Oleo,Edward Epstein,Purva Sharma,Christopher P. Larsen,Vanesa Bijol,Kenar D. Jhaveri +9 more
TL;DR: In this paper, the authors reported two cases of pauci immune glomerulonephritis with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, who clinically improved with treatment of COVID-19 and cautious use of immunosuppressants.